title: COX-2 is a novel target in therapy of mycosis fungoides.
authors.forename: K L M
authors.initials: KL
authors.lastname: Kopp
authors.forename: S
authors.initials: S
authors.lastname: Dabelsteen
authors.forename: T
authors.initials: T
authors.lastname: Krejsgaard
authors.forename: K W
authors.initials: KW
authors.lastname: Eriksen
authors.forename: C
authors.initials: C
authors.lastname: Geisler
authors.forename: J C
authors.initials: JC
authors.lastname: Becker
authors.forename: M
authors.initials: M
authors.lastname: Wasik
authors.forename: N
authors.initials: N
authors.lastname: Ødum
authors.forename: A
authors.initials: A
authors.lastname: Woetmann
mesh_terms: D000818:Animals; D000068579:Celecoxib; D045744:Cell Line, Tumor; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019394:Ki-67 Antigen / Q000032:analysis; D051379:Mice; D009182:Mycosis Fungoides / Q000188:drug therapy*; D011720:Pyrazoles / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D023041:Xenograft Model Antitumor Assays
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D019394:Ki-67 Antigen; C498355:Mki67 protein, mouse; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib